• Contineum Therapeutics, Inc. (NASDAQ:CTNM) Given Average Recommendation of "Buy" by Brokerages

    Источник: Buzz FX / 14 мар 2025 14:07:17   America/Chicago


    Contineum Therapeutics, Inc. (NASDAQ:CTNM) Given Average Recommendation of "Buy" by Brokerages Written by MarketBeat March 14, 2025 Share Link copied to clipboard. Remove Ads Contineum Therapeutics, Inc.
    Read more...
Опубликовать